Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

1ALNY

MTA
272.70001 EUR
0.1
0.04%
Last update May 14, 11:04 AM CEST
Main market
Day range
272.70001
272.70001
Previous close
272.79999
Open
272.70001
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
272.70
0.10
0.04%

Statistics

Valuation metrics
Market cap
40.44B
Enterprise value
30.42B
Trailing P/E (ttm)
Forward P/E
PEG ratio
Price/Sales (ttm)
17.22
Price/Book (mrq)
298.42
Enterprise Value/Revenue
15.18
Enterprise Value/EBITDA
-616.57
Overview
Shares outstanding
129.29M
Float
125.46M
Shares short
% Held by insiders
3.83%
% Held by institutions
97.50%
Average volume (10 days)
0
Average volume (90 days)
0
Price summary
52-Week low
213.10
52-Week high
278.10
52-Week change
21.86 10.3%
Beta
0.21
50-Day moving average
255.27
200-Day moving average
255.27
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Mar 31, 2025
Profitability
Profit margin
-11.49%
Operating margin
3.04%
Operational effectiveness
Return on assets
-1.79%
Return on equity
-414.62%
Income statement
Revenue (ttm)
2.00B
Revenue per share (ttm)
18.27
Quarterly revenue growth (yoy)
20.20%
Gross profit (ttm)
1.72B
EBITDA
-49.33M
Net income to common (ttm)
-230.14M
Diluted EPS (ttm)
-1.79
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
2.25B
Total cash per share (mrq)
20.19
Total debt (mrq)
2.32B
Total Debt/Equity (mrq)
2.36K
Current ratio (mrq)
303.80%
Book value per share (mrq)
0.89
Cash flow
Cash flow statement
-38.49M
Levered free cash flow (LFCF)
190.36M
Main market

Exchange is currently active.
Closing in 4 hours 59 minutes

12:30
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CEST, UTC+02:00).